• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.03% Nasdaq Up 0.29%

    More On DIVISLAB.NS

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    Divi's Laboratories Limited (DIVISLAB.NS)

    -NSE
    1,678.45 Up 22.45(1.36%) Jan 23
    Add to Portfolio
    Prev Close:1,656.00
    Open:1,661.00
    Bid:N/A
    Ask:N/A
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:1,661.00 - 1,684.90
    52wk Range:1,210.00 - 1,888.05
    Volume:142,212
    Avg Vol (3m):142,306
    Market Cap:222.79B
    P/E (ttm):28.81
    EPS (ttm):58.26
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in INR.

    Headlines

    • No Headlines available for DIVISLAB.NS at this time.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):8.70
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Divi’s Laboratories Limited manufactures and sells active pharmaceutical ingredients (API) and intermediates for generics in India. The company also offers building blocks for peptides and nucleotides; carotenoids, such as apocarotenal, betac... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback